TY - JOUR
T1 - 735. Severity and Healthcare Costs of Respiratory Syncytial Virus Hospitalizations in US Preterm Infants Born at 29–34 Weeks Gestation: 2014–2016
AU - Goldstein, Mitchell R.
AU - Krilov, Leonard R
AU - Fergie, Jaime
AU - Ambrose, Christopher S
AU - Wade, Sally
AU - Kong, Amanda
AU - Brannman, Lance
N1 - AbstractBackground. In 2014, the American Academy of Pediatrics recommended against the use of respiratory syncytial virus (RSV) immunoprophylaxis in infants 2
PY - 2018/11/26
Y1 - 2018/11/26
N2 - Background. In 2014, the American Academy of Pediatrics recommended against the use of respiratory syncytial virus (RSV) immunoprophylaxis in infants 29-34 weeks gestational age (wGA) at birth without chronic lung disease/bronchopulmonary dysplasia (CLD/BPD) or congenital heart disease (CHD). To inform discussions of the clinical and economic value of RSV immunoprophylaxis in these infants, we compared RSV hospitalization (RSVH) severity and costs incurred by infants hospitalized from 2014-2016 at
AB - Background. In 2014, the American Academy of Pediatrics recommended against the use of respiratory syncytial virus (RSV) immunoprophylaxis in infants 29-34 weeks gestational age (wGA) at birth without chronic lung disease/bronchopulmonary dysplasia (CLD/BPD) or congenital heart disease (CHD). To inform discussions of the clinical and economic value of RSV immunoprophylaxis in these infants, we compared RSV hospitalization (RSVH) severity and costs incurred by infants hospitalized from 2014-2016 at
UR - https://academic.oup.com/ofid/article/5/suppl_1/S264/5207072
UR - https://www.mendeley.com/catalogue/2bbffc2e-5164-3b6d-932a-8b808a95337b/
U2 - 10.1093/OFID/OFY210.742
DO - 10.1093/OFID/OFY210.742
M3 - Meeting abstract
VL - 5
SP - S264-S264
JO - Open Forum Infectious Diseases
JF - Open Forum Infectious Diseases
IS - suppl_1
ER -